Replies to post #79312 on Innovation Pharmaceuticals Inc (IPIX)

[BioHedge]

You're spot on. Bottom line B results are in and I don't expect a PR until after FDA meetings. Consider it an early holiday gift from Leo to all who are still building positions.

[lousy engineer]

CTIX will only be meeting the FDA folks early next month. So they probably won't release the bottom line results for Brilacidin until mid of December 2015.

[farrell90]

I agree. It is likely we will receive several news items soon regarding Brilacidin:

1. Completed FDA 2b study data

2. FDA stage 3 plans for ABSSSI

3. Perhaps application for expedited study which would boost the share price, but since it is likely to be a short study may not make much practical difference.

4. Announcement of FDA plans for ophthalmic, otic and dermatologic Brilacidin studies.

5. I expect we will see an announcement regarding FDA study for other defensin-mimetics in the next few months. There is a critical need for new antibiotics for multiresistant gram negative infections and TB.The FDA should be anxious to facilitate these studies due the the high death rate of the hospital acquired gram negative infections and the positive pharmacologic and safety attributes of the first defensin-mimetic ,Brilacidin.